Skip to content
Luna Metabolic
Menu
Ranked #17 for women · Grade B

REMEVi review

An accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end.

Visit REMEVi Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$199/mo
Tirzepatide
$269/mo
Coverage
All 50 states
Brand-name
Compounded only

The Luna Fit scorecard

REMEVi scored on our six women's-health factors. See the methodology.

PCOS & hormonal suitability83/100
Clinical oversight & labs85/100
Price transparency82/100
Nationwide access95/100
Ongoing support83/100
Cancellation fairness82/100

What we like

  • LegitScript-accredited and available in all 50 states
  • Both molecules disclosed, tirzepatide for insulin-resistant PCOS
  • Clear, predictable pricing

The caveats

  • Higher-end pricing — $199 semaglutide, $269 tirzepatide
  • No oral or brand-name option; general program without hormone specialization

The bottom line

Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. An accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end.

Ranked #17 of 25 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've reviewed for women, in our overall ranking order.

Pricing, states and verification reflect REMEVi's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to all providers